SEARCH

SEARCH BY CITATION

References

  • 1
    Williams Rc Jr. Cellular mechanism of tissue injury and immune derangement in systemic lupus erythematosus. Arthritis Rheum 1982; 25: 8103.
  • 2
    Mohan C & Datta SK. Lupus: key pathogenic mechanisms and contributing factors. Clin Immunol Immunopathol 1995; 77: 20920.DOI: 10.1006/clin.1995.1146
  • 3
    Reeves WH, Satoh M, Wang J, Chou CH & Ajmani AK. Systemic lupus erythematosus. Antibodies to DNA, DNA-binding proteins, and histones. Rheum Dis Clin North Am 1994; 20: 128.
  • 4
    Lefkowith JB & Gilkeson GS. Nephritogenic autoantibodies in lupus. Current concepts and continuing controversies. Arthritis Rheum 1996; 39: 894903.
  • 5
    Hahn BH. Antibodies to DNA. N Engl J Med 1998; 338: 135968.
  • 6
    Burlingame RW, Boey ML, Starkebaum G & Rubin RL. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest 1994; 94: 18492.
  • 7
    Chabre H, Amoura Z, Piette J-C, Godeau P, Bach J-F & Koutouzov S. Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 1995; 38: 148591.
  • 8
    Suenaga R & Abdou NI. Anti-(DNA-Histone) antibodies in active lupus nephritis. J Rheumatol 1996; 23: 27985.
  • 9
    Burlingame RW & Rubin RL. Autoantibody to the nucleosome subunit (H2A-H2B)-DNA is an early and ubiquitous feature of lupus-like conditions. Mol Biol Reports 1996; 23: 15966.
  • 10
    Monestier M. Autoantibodies to nucleosomes and histone–DNA complexes. Methods 1997; 11: 3643.
  • 11
    Monestier M & Kotzin BL. Antibodies to histones in systemic lupus erythematosus and drug-induced lupus syndromes. Rheum Dis Clin North Am 1992; 18: 41536.
  • 12
    Rubin RL, Bell SA & Burlingame RW. Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)–DNA complex. J Clin Invest 1992; 90: 16573.
  • 13
    Termaat RM, Brinkman K, Van Gompel F, Van Den Heuvel LP, Veerkamp JH, Smeenk RJ & Berden JH. Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes. J Autoimmun 1990; 3: 53145.
  • 14
    Kramers C, Hylkema MN, Van Bruggen MC, Van De Lagemaat R, Dijkman HB, Assmann KJ, Smeenk RJ & Berden JH. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest 1994; 94: 56877.
  • 15
    Bernstein KA, Valerio RD & Lefkowith JB. Glomerular binding activity in MRL lpr serum consists of antibodies that bind to a DNA/histone/type IV collagen complex. J Immunol 1995; 154: 242433.
  • 16
    Amoura Z, Chabre H, Koutouzov S, Lotton C, Cabrespines A, Bach JF & Jacob L. Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum 1994; 37: 16848.
  • 17
    Burlingame RW, Rubin RL, Balderas RS & Theofilopoulos AN. Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J Clin Invest 1993; 91: 168796.
  • 18
    Mohan C, Adams S, Stanik V & Datta SK. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 1993; 177: 136781.
  • 19
    Desai-Mehta A, Mao C, Rajagopalan S, Robinson T & Datta SK. Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus. J Clin Invest 1995; 95: 53141.
  • 20
    Filaci G, Grasso I & Contini P et al. dsDNA-, nucleohistone- and DNASE I-reactive T lymphocytes in patients affected by systemic lupus erythematosus: correlation with clinical disease activity. Clin Exp Rheumatol 1996; 14: 54350.
  • 21
    Mevorach D, Zhou JL, Song X & Elkon KB. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 1998; 188: 38792.
  • 22
    Morel L, Rudofsky UH, Longmate JA, Schiffenbauer J & Wakeland EK. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1994; 1: 21929.
  • 23
    Morel L, Mohan C, Yu Y, Croker B, Tian X-H, Deng A & Wakeland EK. Functional dissection of SLE pathogenesis using congenic mouse strains. J Immunol 1997; 158: 601928.
  • 24
    Mohan C, Morel L, Croker B, Yang P & Wakeland EK. Genetic dissection of SLE pathogenesis: Sle2 on murine chromosome 4 leads to B-cell hyperactivity. J Immunol 1997; 159: 45465.
  • 25
    Mohan C, Alas E, Morel L, Yang P & Wakeland EK. Genetic dissection of SLE pathogenesis: Sle1 on murine chromosome 1 leads to loss of tolerance to H2A/H2B/DNA subnucleosomes. J Clin Invest 1998; 101: 136272.
  • 26
    Mohan C, Morel L, Yang P & Wakeland EK. Accumulation of splenic B1a cells with potent antigen-presenting capability in NZM2410 lupus-prone mice. Arthritis Rheum 1998; 41: 165262.
  • 27
    Mohan C, Yu Y, Morel L, Yang P & Wakeland EK. Genetic dissection of SLE pathogenesis: Sle3 on murine chromosome 7 impacts T cell activation, differentiation and cell death. J Immunol 1999; 162: 6492502.
  • 28
    Mohan C, Morel L, Yang P, Croker B, Gilkeson G & Wakeland EK. Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies. J Clin Invest 1999; 103: 168595.
  • 29
    Tan EM, Cohen AS & Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 12717.
  • 30
    Burlingame RW & Rubin RL. Subnucleosome structures as substrates in enzyme-linked immunosorbent assays. J Immunol Methods 1990; 134: 18799.
  • 31
    Arnett FC & Reveille JD. Genetics of systemic lupus erythematosus. Rheum Dis Clin North Am 1992; 18: 86592.
  • 32
    Winchester R. Genetic susceptibility to systemic lupus erythematosus. In: LahitaRG, ed. Systemic lupus erythematosus. New York: Churchill Livingstone, 1992: 6585.
  • 33
    Tsao BP. Genetic susceptibility to lupus nephritis. Lupus 1998; 7: 58590.
  • 34
    Gaffney PM, Kearns GM & Shark KB et al. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc Natl Acad Sci USA 1998; 95: 148759.DOI: 10.1073/pnas.95.25.14875
  • 35
    Moser KL, Neas BR & Salmon JE et al. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci USA 1998; 95: 1486974.DOI: 10.1073/pnas.95.25.14869
  • 36
    Kono DH & Theofilopoulos AN. Genetic contributions to SLE. J Autoimmun 1996; 9: 43752.DOI: 10.1006/jaut.1996.0061
  • 37
    Wakeland EK, Morel L, Mohan C & Yui M. Genetic dissection of lupus nephritis in murine models of SLE. J Clin Immunol 1997; 17: 27281.
  • 38
    Vyse TJ & Kotzin BL. Genetic susceptibility to systemic lupus erythematosus. Ann Rev Immunol 1998; 16: 26192.
  • 39
    Mohan C, Morel L & Wakeland EK. Genetic insights into murine lupus. In: KammerGM, Tsokos.GC, eds. Lupus molecular and cellular pathogenesis. Totowa, NJ: Humana Press, 1999: 12439.
  • 40
    Lowenstein MB & Rothfield NF. Family study of systemic lupus erythematosus: analysis of the clinical history, skin immunofluorescence, and serologic parameters. Arthritis Rheum 1977; 20: 1293303.
  • 41
    Cleland LG, Bell DA, Willans M & Saurino BC. Familial lupus. Family studies of HLA and serologic findings. Arthritis Rheum 1978; 21: 18391.
  • 42
    Reveille JD, Bias WB, Winkelstein JA, Provost TT, Dorsch CA & Arnett FC. Familial systemic lupus erythematosus: immunogenetic studies in eight families. Med Baltimore 1983; 62: 2135.
  • 43
    Arnett FC, Hamilton RG, Reveille JD, Bias WB, Harley JB & Reichlin M. Genetic studies of Ro (SS-A) and La (SS-B) autoantibodies in families with systemic lupus erythematosus and primary Sjögren's syndrome. Arthritis Rheum 1989; 32: 4139.
  • 44
    Sato EI, Atra E, Gabriel AJ & Masi AT. Systemic lupus erythematosus: a family study of 25 probands. Clin Exp Rheumatol 1991; 9: 45561.
  • 45
    Tsao BP, Cantor RM & Kalunian KL et al. Evidence for linkage of a candidate chromosome 1 region to systemic lupus erythematosus (SLE). J Clin Invest 1997; 99: 72531.
  • 46
    Kotzin BL. Susceptibility loci for lupus: a guiding light from murine models? J Clin Invest 1997; 99: 5578.
  • 47
    Salmon JE, Millard S & Schachter LA et al. Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 1996; 97: 134854.
  • 48
    Wu J, Edberg JC, Redecha PB, Bansal V, Guyre PM, Coleman K, Salmon JE & Kimberly RP. A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest 1997; 100: 105970.
  • 49
    Harley JB, Moser KL, Gaffney PM & Behrens TW. The genetics of human systemic lupus erythematosus. Curr Opin Immunol 1998; 10: 6906.
  • 50
    Morel L, Tian X-H, Croker BP & Wakeland EK. Epistatic modifiers of autoimmunity in a murine model of lupus nephritis. Immunity 1999; 11: 1319.